Login / Signup

The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada - The IMPACT trial.

Nancy A RisebroughSara MursleenKerigo NdiranguDhvani ShahAlan MartinMelanie SchroederAfisi S Ismaila
Published in: Respiratory medicine (2024)
IMPACT trial NCT02164513.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • chronic obstructive pulmonary disease
  • randomized controlled trial
  • lung function
  • cystic fibrosis
  • smoking cessation